Strikingly, when examining genetic vulnerabilities of YAPoff cancers, two of the top-scoring hits are NAMPT and its partner protein in the NAD + salvage pathway, NMNAT1, matching the drug vulnerability data [14]. Here, NAMPT is linked to cancer.